Volume 271, Number 44,
Issue of November 1, 1996
pp. 27556-27563
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.
2,2
-Dithiobis(N-ethyl-spermine-5-carboxamide) Is a
High Affinity, Membrane-impermeant Antagonist of the Mammalian
Polyamine Transport System
(Received for publication, June 21, 1996, and in revised form, August 13, 1996)
Maria
Huber
,
Joële G.
Pelletier
,
Krikor
Torossian
,
Patricia
Dionne
,
Isabelle
Gamache
,
René
Charest-Gaudreault
§
,
Marie
Audette
and
Richard
Poulin
From the
Laboratory of Molecular Endocrinology, Laval
University Medical Research Center, 2705 Laurier Blvd., Ste. Foy,
Québec, Québec, Canada G1V 4G2 and
§ Hôpital Saint-François d'Assise Research
Center, 10 Rue de l'Espinay,
Québec, Québec, Canada G1L 3L5
We have synthesized
2,2
-dithiobis(N-ethyl-spermine-5-carboxamide) (DESC), its
thiol monomer (MESC), and the mixed MESC-cysteamine disulfide (DEASC)
as potential inhibitors of polyamine transport in mammalian cells. DESC
was the most potent antagonist of spermine transport in ZR-75-1 human
breast cancer cells, with Ki values of 5.0 ± 0.7, 80 ± 31, and 16 ± 3 µM for DESC, MESC,
and DEASC, respectively. DESC also strongly blocked putrescine and
spermidine uptake in ZR-75-1 cells (Ki = 1.6 ± 0.5 and 2.7 ± 1.1 µM, respectively). While DESC
and MESC were purely competitive inhibitors of putrescine transport,
DEASC was a mixed competitive/noncompetitive antagonist. Remarkably,
DESC was virtually impermeant in ZR-75-1 cells despite its low
Ki toward polyamine transport. The marked
difference in affinity between DESC and MESC was essentially due to the
tail-to-tail juxtaposition of two spermine-like structures, suggesting
that dimeric ligands of the polyamine transporter might simultaneously
interact with more than one binding site. While DESC strongly decreased
the initial rate of [3H]spermidine transport, even a
40-fold molar excess of antagonist could not completely abolish
intracellular spermidine accumulation. Moreover, as little as 0.3 µM spermidine fully restored growth in ZR-75-1 cells
treated with an inhibitor of polyamine biosynthesis in the presence of
50 µM DESC, thus emphasizing the importance of uptake of
trace amounts of exogenous polyamines. Thus, reducing the exogenous
supply of polyamines with a potent competitive inhibitor may be
kinetically inadequate to block replenishment of the polyamine pool in
polyamine-depleted tumor cells that display high transport capacity.
These results demonstrate that polyamine analogues cross-linked into a
dimeric structure such as DESC interact with high affinity with the
mammalian polyamine carrier without being used as substrates. These
novel properties provide a framework for the design of specific
irreversible inhibitors of the polyamine transporter, which should
present advantages over competitive antagonists for an efficient
blockade of polyamine transport in tumor cells.